This disclosure relates to early diagnosis and assessment tools for Parkinson's disease, movement disorder, neurological disease, and/or chronic pain, designed to drive innovation and to accelerate best Parkinson's disease, movement disorders, neurological disease, and chronic pain research. The present disclosure facilitates improved access to Parkinson's disease, movement disorders, neurological disease, and chronic pain patients along with innovative data capture methods that are designed to leading to improved therapies and assisting in finding a cure for Parkinson's disease, movement disorders, neurological diseases, and/or chronic pain. In addition the present disclosure is broadly applicable as a diagnosis and assessment tool to all movement disorders and many neurological diseases and/or chronic pain.

 
Web www.patentalert.com

< Computational methods and systems for suggesting modulators of CYP450 as treatment options

< BENZYLAMINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES

> HUMAN CYTOKINE RECEPTOR

> Conditional Mst Overexpressing Construct and Conditional Myostatin Overexpressing Transgenic Mouse

~ 00619